Phalanx Biotech provides genomic products and services worldwide to academic, pharmaceutical, biotech, and clinical researchers. Phalanx Biotech’s expertise in expression profiling and genetic analysis stems from its excellence as an original design manufacturer of OneArray® gene expression microarrays, CytoOneArray® targeted chromosomal microarrays, and its comprehensive knowledge developed as an application-focused service provider. Our dedicated service specialists are trained experts in gene and microRNA expression profiling, and thus can provide top notch technical support from experimental design to bioinformatics data analysis. The OneArray® genomics service lab supports investigators interested in drug discovery, biomarker discovery, toxicogenomics, immunology, cancer genomics, neurobiology, and basic research.

Phalanx Biotech designs and manufactures CytoOneArray, a world-class array-comparative genomic hybridization (aCGH) platform that enables clinical researchers to quickly and reliably detect microdeletions and microduplications for 332 clinically confirmed disease regions and 41 subtelomere regions related to congenital disorders. The CytoOneArray has a backbone area layout designed to avoid common copy number variations, and each probe contains links to peer-reviewed literature related to its associated genetic disease.